trending Market Intelligence /marketintelligence/en/news-insights/trending/96bqj2bfjh_rgoxdcxu4yq2 content esgSubNav
In This List

Biostage adds hospital executive to board

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Biostage adds hospital executive to board

Holliston, Mass.-based Biostage Inc. named James Shmerling as a board member.

Shmerling is the president and CEO of Connecticut Children's Medical Center.

"Biostage is collaborating with Connecticut Children's Medical Center to translate our Cellframe technology from pre-clinical studies to clinical trials to address pediatric esophageal atresia, and the addition of Jim to our board supports the vision of this collaboration," Biostage CEO James McGorry said in a statement.

Biostage is a biotechnology company that engages in developing bioengineered organ implants.